End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
65.14 CNY | +2.96% | +9.11% | -0.17% |
Apr. 19 | Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 16 | Jianmin Pharma Gets Nod to Market Asthma Drug | MT |
Sales 2024 * | 4.93B 681M | Sales 2025 * | 5.68B 784M | Capitalization | 9.9B 1.37B |
---|---|---|---|---|---|
Net income 2024 * | 619M 85.45M | Net income 2025 * | 768M 106M | EV / Sales 2024 * | 2.01 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.74 x |
P/E ratio 2024 * |
16.1
x | P/E ratio 2025 * |
13
x | Employees | 2,497 |
Yield 2024 * |
2.39% | Yield 2025 * |
2.93% | Free-Float | 69.14% |
1 day | +2.96% | ||
1 week | +9.11% | ||
Current month | +14.91% | ||
1 month | +17.07% | ||
3 months | +13.39% | ||
6 months | -2.25% | ||
Current year | -0.17% |
Managers | Title | Age | Since |
---|---|---|---|
Jun Wang
CEO | Chief Executive Officer | 48 | 20-09-08 |
Zhao Yang Cheng
DFI | Director of Finance/CFO | 52 | 18-01-01 |
Qin He
CHM | Chairman | 64 | 03-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Qin He
CHM | Chairman | 64 | 03-12-31 |
Shu Qu Li
BRD | Director/Board Member | 53 | 19-09-04 |
Rong Pei
BRD | Director/Board Member | 53 | 11-08-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-27 | 65.14 | +2.96% | 2 894 551 |
24-05-27 | 63.27 | +3.86% | 2,702,120 |
24-05-24 | 60.92 | -0.77% | 2,002,911 |
24-05-23 | 61.39 | +0.80% | 4,698,537 |
24-05-22 | 60.9 | +0.16% | 2,913,000 |
End-of-day quote Shanghai S.E., May 27, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.17% | 1.33B | |
+37.41% | 727B | |
-7.99% | 354B | |
+15.43% | 328B | |
-0.54% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+3.60% | 164B | |
-2.10% | 164B |
- Stock Market
- Equities
- 600976 Stock